KORTUC Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
KORTUC General Information
Description
Developer of radio sensitizing cancer treatment technology intended to improve the effectiveness of radiotherapy for solid tumors. The company's platform utilizes an injectable formulation based on hydrogen peroxide and sodium hyaluronate to reduce tumor hypoxia and address radiotherapy resistance, includes a prefilled injection device kit for clinical administration, supports integration with existing radiation treatment workflows, and is being evaluated across multiple solid tumor types, enabling healthcare providers to enhance radiotherapy outcomes for patients with treatment-resistant cancers.
Contact Information
Website
kortuc.comCorporate Office
- 214 Homer Avenue
- Palo Alto, CA 94301
- United States
Corporate Office
- 214 Homer Avenue
- Palo Alto, CA 94301
- United States
KORTUC Timeline
KORTUC Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-Jul-2026 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series B) | 08-Aug-2025 | Completed | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC (Series C) | 05-Nov-2021 | Completed | Clinical Trials - Phase 2 | |||
| 4. Early Stage VC | 20-Sep-2019 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC (Series B) | 10-Jan-2019 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 28-Dec-2017 | $868K | $1.75M | Completed | Clinical Trials - Phase 1 | |
| 1. Seed Round | 28-Feb-2017 | $884K | $884K | Completed | Clinical Trials - Phase 1 |
KORTUC Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class C Preferred | ||||||||
| Class B Preferred | ||||||||
| Class A3 Preferred | ||||||||
| Class A2 Preferred | 1,633 | $528.14 | $528.14 | $528.14 | 8.94% | |||
| Class A Preferred | 2,380 | $369.7 | $369.7 | $369.7 | 13.03% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
KORTUC Comparisons
Industry
Financing
Details
KORTUC Competitors (1)
One of KORTUC’s competitors is Nanobiotix, a Formerly VC-backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nanobiotix | Formerly VC-backed | Paris, France |
KORTUC Patents
KORTUC Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4166147-A1 | Sensitiser for cancer treatment | Inactive | 15-Jun-2020 | ||
| EP-4166147-A4 | Sensitiser for cancer treatment | Inactive | 15-Jun-2020 | ||
| WO-2021256427-A1 | Sensitiser for cancer treatment | Inactive | 15-Jun-2020 | ||
| JP-2022168328-A | Sensitizer for anticancer therapy | Pending | 15-Jun-2020 | ||
| JP-2021000262-A | Syringe and kit suitable for hydrogen peroxide solution | Active | 21-Jun-2019 |
KORTUC Signals
KORTUC Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Loyal VC | Venture Capital | Minority | ||
| Midas Capital (Japan) | PE/Buyout | Minority | ||
| AXA Japan | Corporation | Minority | ||
| Irimajiri Group | Corporation | Minority | ||
| SBI Investment | Venture Capital | Minority |
KORTUC FAQs
-
When was KORTUC founded?
KORTUC was founded in 2015.
-
Where is KORTUC headquartered?
KORTUC is headquartered in Palo Alto, CA.
-
What is the size of KORTUC?
KORTUC has 3 total employees.
-
What industry is KORTUC in?
KORTUC’s primary industry is Biotechnology.
-
Is KORTUC a private or public company?
KORTUC is a Private company.
-
What is KORTUC’s current revenue?
The current revenue for KORTUC is .
-
How much funding has KORTUC raised over time?
KORTUC has raised $44.4M.
-
Who are KORTUC’s investors?
Loyal VC, Midas Capital (Japan), AXA Japan, Irimajiri Group, and SBI Investment are 5 of 8 investors who have invested in KORTUC.
-
Who are KORTUC’s competitors?
Nanobiotix is a competitor of KORTUC.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process